Plain-English translation of NCT05689151 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →This study is looking at how well works for people with moderate-to-severe eczema in real-world conditions. You would take this medication as a daily tablet, and researchers would check in with you regularly over 2 years to see how it helps your skin and whether you experience any side effects.
While this medication has been approved for eczema treatment, doctors want to understand how it performs when patients use it in their daily lives—not just in controlled research settings. This will help them learn if it truly makes a difference for people dealing with persistent, bothersome eczema.
You likely qualify if…
You likely don't qualify if…
You would take as a daily tablet for up to 24 months while continuing to use any skin creams or lotions you currently use. You would visit the study clinic about 5 times (roughly every 4 to 6 months) so doctors can examine your skin, check for any side effects, and ask how the medication is working for you in your everyday life.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
France